Home > News > St. Joseph's Among First in U.S. to Use New Technology
January 19th, 2004
St. Joseph's Among First in U.S. to Use New Technology
Researchers at St. Joseph's Hospital and Medical Center are among the first in the country to use a new molecular diagnostic tool to help develop genetic tests for Alzheimer's disease. St. Joseph's DNA Diagnostic Laboratories validated the test in collaboration with Nanogen, Inc., a company that develops and commercializes molecular diagnostic products for the gene-based testing market.
Aptasensors Help Detection of Cancer Protein Marker March 9th, 2014
Nano Labs Shareholder Update March 8th, 2014
MANA Research Highlight: Smart nanofibers to treat kidney failure March 6th, 2014
Harris & Harris Group, Inc. Establishes and Invests $350,001 in ProMuc, Inc. March 6th, 2014